Global growth worries, J&J's tumble drag Wall St. lower
Reuters
Published Dec 14, 2018 03:10PM ET
Global growth worries, J&J's tumble drag Wall St. lower
By Sinéad Carew
(Reuters) - U.S. stocks slumped on Friday as weak data from China and Europe stoked fears of a global economic slowdown, while Johnson & Johnson slid after Reuters reported the company knew for decades that asbestos lurked in its Baby Powder.
Investors worried about global growth after China reported weak monthly retail sales growth and industrial output numbers, as disappointing economic data was released from Euro zone.
The Johnson & Johnson (N:JNJ) report, which the company has disputed, sent its shares tumbling 10.2 percent in heavy volume, making it the biggest drag on the S&P 500 and the Dow Industrials.
The pharma major also pulled down the S&P healthcare index (SPXHC) 3.6 percent, making it the biggest decliner among the 11 major sectors. The technology index (SPLRCT), which includes a number of companies with global operations, especially China, dropped 2.4 percent.
Strong U.S. retail sales data appeared to have little impact on markets, with the S&P retail sector <.SPXRT> falling 2 percent.
"Solid fundamental data that gets to the core of the U.S. economy is overshadowed by the potential for a global slowdown washing up on our shores," said Phil Blancato, chief executive of Ladenburg Thalmann Asset Management in New York.
But Blancato said he does not buy the thesis that slowing growth outside of the United States will hurt the U.S. economy and that the decline was a buying opportunity.
At 2:57 p.m. EST (1947 GMT), the Dow Jones Industrial Average (DJI) was down 472.77 points, or 1.92 percent, to 24,124.61, the S&P 500 (SPX) lost 47.63 points, or 1.80 percent, to 2,602.91 and the Nasdaq Composite (IXIC) dropped 140.11 points, or 1.98 percent, to 6,930.22.
The market has struggled this week with choppy trading and has failed to hold on to opening levels in magnitude or direction on concerns ranging from U.S.-China trade talks, interest rates and a flattening U.S. Treasury yield curve to uncertainty over the shape of Brexit.
But investors appeared to shrug off Beijing's announcement it would suspend additional tariffs on U.S.-made vehicles and auto parts for three months starting Jan. 1.
The S&P healthcare sector was last down 3.5 percent followed by a 2.7 percent decline in the energy index (SPNY) and technology stocks, which were down 2.4 percent.
Costco Wholesale Corp (O:COST) dropped 9 percent after reporting a fall in quarterly gross margin and was the biggest laggard in consumer staples.
Walgreens Boots Alliance Inc (O:WBA) was another healthcare stock that declined, down 4.5 percent, after Goldman Sachs (NYSE:GS) downgraded the drugstore owner's shares.
Apple Inc (O:AAPL) fell 2.8 percent, with some reports citing a top analyst slashing an iPhone sales estimate for the decline.
Get The News You Want
Declining issues outnumbered advancing ones on the NYSE by a 3.90-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.
The S&P 500 posted nine new 52-week highs and 84 new lows; the Nasdaq Composite recorded six new highs and 367 new lows.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.